Leonard Resignation Leaves AAM Looking For New Leadership

Gaugh Steps In As Interim CEO Of US Generics And Biosimilars Association

Dan Leonard has announced his resignation as president and CEO of the US Association for Accessible Medicines. He will be replaced on an interim basis by the group’s vice president for sciences and regulatory affairs, David Gaugh.

Replacement of leader, CEO, wooden figures
As interim CEO, David Gaugh has replaced Dan Leonard • Source: Shutterstock

The US Association for Accessible Medicines is now looking for a new permanent leader, after the generics and biosimilars industry association announced that its current chief Dan Leonard would be stepping down from the position with immediate effect.

In a statement published by the AAM, Leonard said “today, I am announcing my resignation from the role of president...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

Wagner Adds Germany To Role As Stada Simplifies Structure

Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.

ADHD

This is regarding ADHD.

test

More from Generics Bulletin

GB-Business-Free-Podcast-The Secret to Walking More: It’s Not Counting Steps - Clone

 
• By 

We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.